# A Study of ALKS 5461 in Healthy Volunteers

> **NCT02068105** · PHASE1 · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 104 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** ALKS 5461
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02068105
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02068105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02068105, "A Study of ALKS 5461 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02068105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*